Insider Transactions in Q1 2025 at Arcus Biosciences, Inc. (RCUS)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 27
2025
|
Terry J Rosen Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
19,800
+0.77%
|
$198,000
$10.18 P/Share
|
|
Feb 27
2025
|
Yasunori Kaneko Director |
BUY
Open market or private purchase
|
Direct |
20,000
+41.32%
|
$200,000
$10.06 P/Share
|
|
Feb 18
2025
|
Gilead Sciences Inc > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
1,363,636
+4.16%
|
$14,999,996
$11.0 P/Share
|
|
Feb 10
2025
|
Richard Markus Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
75,193
+50.0%
|
-
|
|
Jan 23
2025
|
Alexander Azoy Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
17,100
+36.16%
|
-
|
|
Jan 23
2025
|
Ii Robert C. Goeltz Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
37,000
+27.58%
|
-
|
|
Jan 23
2025
|
Jennifer Jarrett Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+18.98%
|
-
|
|
Jan 23
2025
|
Terry J Rosen Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
165,000
+6.11%
|
-
|
|
Jan 23
2025
|
Carolyn C. Tang General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
37,000
+21.19%
|
-
|
|
Jan 23
2025
|
Juan C. Jaen President |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+11.98%
|
-
|